Correction: Further investigation of phenotypes and confounding factors of progressive ratio performance and feeding behavior in the BACHD rat model of Huntington disease

[This corrects the article DOI: 10.1371/journal.pone.0173232.].

[1]  O. Riess,et al.  Further investigation of phenotypes and confounding factors of progressive ratio performance and feeding behavior in the BACHD rat model of Huntington disease , 2017, PloS one.

[2]  C. Calaminus,et al.  Olesoxime suppresses calpain activation and mutant huntingtin fragmentation in the BACHD rat. , 2015, Brain : a journal of neurology.

[3]  M. de Tommaso,et al.  Dysphagia in Huntington's Disease: Correlation with Clinical Features , 2015, European Neurology.

[4]  H. Grill,et al.  Leptin receptor signaling in the lateral parabrachial nucleus contributes to the control of food intake. , 2014, American journal of physiology. Regulatory, integrative and comparative physiology.

[5]  O. Riess,et al.  Automated phenotyping and advanced data mining exemplified in rats transgenic for Huntington's disease , 2014, Journal of Neuroscience Methods.

[6]  H. Grill,et al.  Leptin Signaling in the Medial Nucleus Tractus Solitarius Reduces Food Seeking and Willingness to Work for Food , 2014, Neuropsychopharmacology.

[7]  M. Hayden,et al.  Choosing an animal model for the study of Huntington's disease , 2013, Nature Reviews Neuroscience.

[8]  Zhen-hua Chen,et al.  Effects of CB1 receptor blockade on monosodium glutamate induced hypometabolic and hypothalamic obesity in rats , 2013, Naunyn-Schmiedeberg's Archives of Pharmacology.

[9]  P. Murray,et al.  Endocrine Control of Growth , 2013, American journal of medical genetics. Part C, Seminars in medical genetics.

[10]  C. Calaminus,et al.  A Novel BACHD Transgenic Rat Exhibits Characteristic Neuropathological Features of Huntington Disease , 2012, The Journal of Neuroscience.

[11]  C. Jodka,et al.  Interactions of amylinergic and melanocortinergic systems in the control of food intake and body weight in rodents , 2012, Diabetes, obesity & metabolism.

[12]  S. Dunnett,et al.  Profiles of motor and cognitive impairment in the transgenic rat model of Huntington's disease , 2012, Brain Research Bulletin.

[13]  S. Dunnett,et al.  Operant-based instrumental learning for analysis of genetically modified models of Huntington's disease , 2012, Brain Research Bulletin.

[14]  O. Stiedl,et al.  Finding the right motivation: Genotype-dependent differences in effective reinforcements for spatial learning , 2012, Behavioural Brain Research.

[15]  J. Mauer,et al.  Mutant huntingtin causes metabolic imbalance by disruption of hypothalamic neurocircuits. , 2011, Cell metabolism.

[16]  Jon F. Davis,et al.  Leptin Regulates Energy Balance and Motivation Through Action at Distinct Neural Circuits , 2011, Biological Psychiatry.

[17]  Elena Cattaneo,et al.  Molecular mechanisms and potential therapeutical targets in Huntington's disease. , 2010, Physiological reviews.

[18]  P. Eling,et al.  Apathy Is Not Depression in Huntington’s Disease , 2009 .

[19]  M. Hayden,et al.  Prevention of depressive behaviour in the YAC128 mouse model of Huntington disease by mutation at residue 586 of huntingtin. , 2008, Brain : a journal of neurology.

[20]  Joseph Jankovic,et al.  Symptomatic treatment of Huntington disease , 2008, Neurotherapeutics.

[21]  D. Figlewicz,et al.  Intraventricular insulin and leptin decrease sucrose self-administration in rats , 2006, Physiology & Behavior.

[22]  P. Bartolomeo,et al.  Cognitive Impairment Related to Apathy in Early Huntington’s Disease , 2006, Dementia and Geriatric Cognitive Disorders.

[23]  N. Cosford,et al.  Metabotropic Glutamate Receptor mGlu5 Is a Mediator of Appetite and Energy Balance in Rats and Mice , 2005, Journal of Pharmacology and Experimental Therapeutics.

[24]  K. Behar,et al.  Comparing adiposity profiles in three mouse models with altered GH signaling. , 2004, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[25]  G. Kusek,et al.  Differences among eight inbred strains of mice in motor ability and motor learning on a rotorod , 2003, Genes, brain, and behavior.

[26]  I. Robinson,et al.  Growth hormone-releasing hormone (GHRH) neurons in GHRH-enhanced green fluorescent protein transgenic mice: a ventral hypothalamic network. , 2003, Endocrinology.

[27]  S Margetic,et al.  Leptin: a review of its peripheral actions and interactions , 2002, International Journal of Obesity.

[28]  M. Low,et al.  Selective Reward Deficit in Mice Lacking β-Endorphin and Enkephalin , 2002, The Journal of Neuroscience.

[29]  D. Neary,et al.  Behavior in Huntington's disease: dissociating cognition-based and mood-based changes. , 2002, The Journal of neuropsychiatry and clinical neurosciences.

[30]  Jane S. Paulsen,et al.  Neuropsychiatric aspects of Huntington's disease , 2001, Journal of neurology, neurosurgery, and psychiatry.

[31]  T. Robbins,et al.  Effects of regional striatal lesions on motor, motivational, and executive aspects of progressive-ratio performance in rats. , 1999, Behavioral neuroscience.

[32]  J. Proietto,et al.  Reduced BAT function as a mechanism for obesity in the hypophagic, neuropeptide Y deficient monosodium glutamate-treated rat , 1998, Regulatory Peptides.

[33]  M. Hayden,et al.  The likelihood of being affected with Huntington disease by a particular age, for a specific CAG size. , 1997, American journal of human genetics.

[34]  J. Penney,et al.  Trinucleotide repeat length instability and age of onset in Huntington's disease , 1993, Nature Genetics.

[35]  Manish S. Shah,et al.  A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes , 1993, Cell.

[36]  B. Bloch,et al.  Growth hormone-releasing hormone-synthesizing neurons are a subpopulation of somatostatin receptor-labelled cells in the rat arcuate nucleus: a combined in situ hybridization and receptor light-microscopic radioautographic study. , 1992, Neuroendocrinology.

[37]  F. Walker,et al.  Dysphagia in Huntington's Disease , 1989, The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses.

[38]  A. Scallet,et al.  Components of hypothalamic obesity: bipiperidyl-mustard lesions add hyperphagia to monosodium glutamate-induced hyperinsulinemia , 1986, Brain Research.

[39]  N. Ling,et al.  Specific depletion of immunoreactive growth hormone-releasing factor by monosodium glutamate in rat median eminence , 1984, Nature.

[40]  Kazuhiko Tanaka,et al.  Hypothalamic lesion induced by injection of monosodium glutamate in suckling period and subsequent development of obesity , 1978, Experimental Neurology.

[41]  G M Besser,et al.  Hypothalamic regulatory hormones: a review. , 1974, Journal of clinical pathology.

[42]  Y. Temel,et al.  Transgenic Rat Models of Huntington's Disease. , 2015, Current topics in behavioral neurosciences.

[43]  S. Dunnett,et al.  Mouse Models of Huntington's Disease. , 2015, Current topics in behavioral neurosciences.

[44]  D. Craufurd,et al.  Longitudinal evaluation of neuropsychiatric symptoms in Huntington's disease. , 2012, The Journal of neuropsychiatry and clinical neurosciences.

[45]  A. Reiner,et al.  Genetics and neuropathology of Huntington's disease. , 2011, International review of neurobiology.

[46]  Min-Yu Chung,et al.  Two-year body composition analyses of long-lived GHR null mice. , 2010, The journals of gerontology. Series A, Biological sciences and medical sciences.

[47]  K. Nader,et al.  Neurobiological constraints on behavioral models of motivation. , 1997, Annual review of psychology.

[48]  L. Donahue,et al.  Growth hormone deficiency in 'little' mice results in aberrant body composition, reduced insulin-like growth factor-I and insulin-like growth factor-binding protein-3 (IGFBP-3), but does not affect IGFBP-2, -1 or -4. , 1993, The Journal of endocrinology.

[49]  M. C. Kagel,et al.  Dysphagi in Huntington's disease: A 16-year retrospective , 1992, Dysphagia.

[50]  M. C. Kagel,et al.  Dysphagia in Huntington's disease. , 1985, Archives of neurology.